SGLT-2 inhibitors and GLP-1 receptor agonists should be avoided during breastfeeding unless specifically advised by your specialist
Guidance such as the ADA/EASD Management of hyperglycaemia in type 2 diabetes consensus report (Davies et al, 2022) recommends early initiation of GLP-1 RAs or SGLT2 inhibitors along with metformin in those with established or high risk of cardiovascular disease, and it is usual practice to titrate one drug up fully before adding the second class, without waiting for further glycaemic assessment
October 2024 Retatrutide: A Breakthrough in Effective Weight Loss Medication Weight loss drugs have been gaining significant attention in the medical community, and the latest entrant, Retatrutide, is already turning heads for its unique approach to weight management
P., Liberator, P
When you apply copper peptides to your scalp, you are essentially treating it with an anti-aging serum
A hot car, sunny windowsill, beach bag, or mailbox in summer is not